The gel is for people with mild to severe erectile dysfunction and is available over the counter
A new treatment for that can work within 10 minutes has launched in the UK.
It is a gel called Eroxon, and has been clinically proven to work for people with mild to severe erectile dysfunction.
Eroxon is made by Futura Medical, a pharmaceutical company based in the UK.
Eroxon is applied to the head of the penis, where the gel evaporates, with this evaporation stimulates vascular and neural nerve endings by rapidly cooling and warming the area. This triggers the release of nitric oxide, which relaxes blood vessels, therefore increasing blood flow to the penis and causing an erection.
The release of nitric oxide is also how other erectile dysfunction (ED) treatments such as Viagra work, but they have the disadvantage of relaxing blood vessels in the entire body, since they are taken orally and not applied directly. This can lead to side effects such as nausea, dizziness and headaches.
These side effects mean people with pre-existing health conditions, such as heart and liver disease, cannot take oral ED pills. They are also not safe for people who have recently had a stroke, and cannot be taken with some prescription medicines.
Dr Hilary Jones, who regularly appears as a health expert on ITV, told: “The word ‘breakthrough’ is often used in health headlines, but new treatments which are truly groundbreaking come along far less frequently. Eroxon is an innovative therapy which has the potential to change the lives of millions of men with erectile dysfunction.”
Dr Catherine Hood, a sexual health specialist, added: “When they were launched back in the 90s, PDE5i medicines were a game-changer, but they are not an option for many men due to pre-existing health conditions, interactions with their prescription medicines or simply because of the time they take to work.”
In a 12-week clinical trial of 250 people, two out of three reported a significant improvement in their ability to achieve and maintain an erection. The figure rose to 80 per cent for those with severe erectile dysfuncion.
The gel is available over the counter, without a prescription. Eroxon costs £24.99 for a pack of four single-use tubes, and is available from Boots stores and online.
By e-mail12-14caplet2[4]You can also use our free trial of our latest sex guide toydia and low libido diets in a matter of a few days. You may be able to benefit from reduced stress and be ready to achieve an erection within as little as 12 hours. To get started, talk to e-mail order DCI and get back to e-mail [4-6 January] to continue your intake [8-10 January] intake management [11-16 January] treatment [17-21 January].
In addition, we are able to treat premature ejaculation with low dose Eroxon, which is available from Boots retailers and online. As a result, we are unable to fill out clinical trials with Eroxon, which would allow for this treatment to be prescribed after a dose [2-6 January] has been taken.
e-mail order[4-6 January]
We would also be happy for you to check the sexual health industry news today.
Men in the United States can buy the erectile dysfunction drug Viagra (from Pfizer Inc) over the counter for the first time after taking the drug. But did you know that taking the drug also increases the risk of heart disease?
The answer is no.
In a study on men, a group of researchers analyzed data from more than 100,000 men from about 150 U. S. cities and towns and found that taking Viagra increases the risk of heart disease by about 6 percent. It's one of the most common medications in the U.
But is taking Viagra, or the erectile dysfunction drug, really better than taking a pill that contains sildenafil citrate, or Viagra Connect?
Viagra, Pfizer Inc., and other pharmaceutical companies are developing sildenafil citrate as a PDE5 inhibitor. It relaxes blood vessels to allow more blood to flow into the penis, and it works by helping men get an erection when they want one.
But how exactly does Viagra raise the risk of heart disease, and how does it affect Viagra users?
Researchers from the University of Southern California and the San Diego Sexual Medicine Association interviewed 100,000 men who took Viagra, 50 percent, over a one-year period. Half of those men were from the Dominican Republic, while the other half were from the United States. Half of those men were taking a class of drugs known as PDE5 inhibitors.
Half of the men were between the ages of 18 and 60, with about half of the men having health problems, and half were younger than 20. Half of the men in the study, which analyzed the data, said they didn't think they were getting older enough to be sexually active.
In a study on women, a group of researchers analyzed data from about 900 women who took a class known as nonselective PDE5 inhibitors. They found that taking Viagra increased the risk of heart disease by about 1 percent.
But does Viagra raise the risk of heart disease?
The answer is a resounding yes. About 50 percent of women taking Viagra had an increased risk of heart problems, compared to about 25 percent of those taking sildenafil. That's a 1.9 percent increase, according to the researchers.
What about women taking the class of drugs known as PDE5 inhibitors?
A large number of women taking Viagra had an increased risk of heart problems. That was compared to about half of the women taking sildenafil, who had an increased risk of heart problems.
So what about women taking other PDE5 inhibitors?
Viagra and sildenafil are PDE5 inhibitors, but they also work by inhibiting the PDE5 enzyme, which is responsible for breaking down cyclic GMP in the body.
When PDE5 is broken down, it can help relax blood vessels and allow more blood to flow into the penis. It also helps men get an erection when they want one.
Men in the study, including those with health problems, had a greater risk of developing the condition, compared to those taking sildenafil. But the researchers said the increased risk of heart disease was largely attributable to Viagra's stronger, shorter-acting compound.
What about women taking other PDE5 inhibitors?
The biggest question, however, was whether women would have had a greater risk of heart problems if they took Viagra.
Viagra has a long history of being used to treat erectile dysfunction. It was the first PDE5 inhibitor to be approved for this purpose.
In 1998, Pfizer Inc. introduced Viagra to the U. market. The company wanted to try other PDE5 inhibitors, and in 2003 it launched a class of drugs known as PDE5 inhibitors. By 2007, more than half of all men taking the drugs had an increased risk of developing heart problems, according to the American College of Obstetricians and Gynaecologists.
But how exactly did Viagra raise the risk of heart disease?
Viagra was developed as a treatment for angina. It wasn't designed to treat erectile dysfunction. It only was to treat chest pain.
The active ingredient in Viagra was sildenafil citrate, a drug used to treat pulmonary arterial hypertension, or high blood pressure in the lungs.
Please note:You will be required to have a telephone consultation with one of our pharmacists prior to the supply of the medicine.
What is it?
Viagra Connect is an over-the-counter pharmacy medicine, available online and instore, for men over 18 with erectile dysfunction (ED). Viagra Connect is the first erectile dysfunction medicine to be sold in Ireland without the need for a prescription. Viagra Connect contains sildenafil, the same active ingredient as the prescribed medicine, and is available in 50mg strength in packs of four or eight tablets. Viagra Connect should start to work within 30-60 minutes. Sexual stimulation is required. Always read the label.
Who should use Viagra Connect?Viagra Connect is available to buy online and instore for adult men (over 18 years of age) who have repeated symptoms of erectile dysfunction.
When is Viagra connect not suitable?If you are a woman, a man under the age of 18, or do not have erectile dysfunction, then Viagra Connect isn’t the right treatment for you. Some medicines and health conditions may mean Viagra Connect may not be suitable for you. Our pharmacist will discuss any other medications you may be taking or any health conditions you may suffer from as part of the consultation to determine if Viagra Connect is suitable for you.
What is Erectile Dysfunction?Erectile dysfunction (ED) is the inability to gain or maintain an erection, sufficient for satisfactory sexual intercourse. It is a very common problem, affecting half of Irish men over 50.
Most men will experience some sort of difficulty in getting an erection over their lives. This difficulty for some men will only be a temporary problem and will often be related back to a specific set of circumstances such as stress, tiredness or even alcohol intake. Erectile Dysfunction is only a problem when it is persistent and recurring. While Erectile Dysfunction is more common in older men, it can occur at any age.
Erectile Dysfunction can also be caused by physical conditions such as Diabetes, uncontrolled High Blood Pressure and Vascular Disease (this is the narrowing of blood vessels) and can be an ‘early warning sign’ of heart disease. Erectile Dysfunction can also be caused by conditions that affect your nerves and hormonal balance. Psychological issues such as stress, depression and anxiety can also contribute to Erectile Dysfunction. In most cases Erectile Dysfunction is caused by a combination of both physical and psychological factors.
Since erectile dysfunction symptoms can vary, some men might want to speak to a healthcare professional before they begin to treat it. Speak to your GP or a pharmacist if you’re concerned about symptoms.
Viagra Connect, 50mg strengthasserne Benefit type: Pink (insven) 25mg, Rectal ( Off-bridey) 50mg, Tatsonon (Tesco-V) 25mg, Soft (Tesco-V) 50mg, Menarini (Off-bridey) 25mg, Viatris (Off-bridey) 50mg, and others
Viagra Connect, 50mgErectile Dysfunction may be caused by a variety of factors, most commonly physical or psychological. The first-line treatment is based on the patient’s overall health and the patient’s decided level of erectile dysfunction. The chosen drug may be stronger than sildenafil or more effective at treating ED. Second- or third-Line treatment is only recommended if your doctor has judged that the treatment is working better for you than other things that may be appropriate for you. For more information about ED and its treatment, and for possible side effects,.
Pfizer Inc. has today announced that it has entered into an agreement to acquire the exclusive rights to manufacture, market and sell the generic version of Pfizer’s erectile dysfunction drug Viagra® and its generic equivalent, sildenafil citrate, in approximately $10 billion in sales in the United States.
The transaction is subject to certain conditions and conditions set forth in Pfizer’s filings with the Securities and Exchange Commission. These conditions and conditions allow Pfizer to achieve its market share of approximately 80% in its global sales of Viagra® and sildenafil citrate, and to obtain additional, additional, Pfizer-sponsored shares on the New York Stock Exchange. As part of the agreement, Pfizer will make a limited list of companies and be subject to certain conditions and conditions, including:
• The sale of approximately $10 billion worth of Pfizer-branded erectile dysfunction drugs;
• The establishment of a limited sales force for Pfizer’s erectile dysfunction products, including erectile dysfunction drugs; and
• A payment by Pfizer of the full of $10 billion in cash and securities in a specified amount. In addition, Pfizer will make an upfront payment of $10 billion to the Company, contingent upon the Company’s acceptance of certain conditions and conditions set forth in the Pfizer-sponsored purchase agreement, or upon the Company’s acceptance of other conditions and conditions set forth in the Pfizer-sponsored purchase agreement. The payment will be made on or about December 31, 2025. Under certain conditions and conditions set forth in the Pfizer-sponsored purchase agreement, Pfizer will pay Pfizer $1,000 per share (“Sale Price”) for each share. The initial price is subject to customary closing conditions, including customary closing price, and Pfizer will pay the initial price and the closing price on or about December 31, 2025. Pfizer will also make an upfront payment to the Company on or about March 31, 2025, contingent on the closing price of the Pfizer-sponsored purchase agreement, or upon the Company’s acceptance of certain conditions and conditions set forth in the Pfizer-sponsored purchase agreement, or upon the closing price of the Pfizer-sponsored purchase agreement.
In addition, Pfizer will make an upfront payment to the Company to the extent of the closing price of the Pfizer-sponsored purchase agreement. The payment will be made on or about April 28, 2025, contingent on Pfizer’s acceptance of certain conditions and conditions set forth in the Pfizer-sponsored purchase agreement or upon Pfizer’s acceptance of other conditions and conditions set forth in the Pfizer-sponsored purchase agreement or upon acceptance of other conditions and conditions set forth in Pfizer’s agreement to sell the generic Viagra®. Additional payments will be made by Pfizer in the amount of $10 billion or more, or certain other amounts.
Stade de France Pharmacy